STOCK Pax7tm1(cre)Mrc Mapk14tm2Nbr/JpellH

Status

Available to order

EMMA IDEM:09446
Citation informationRRID:IMSR_EM:09446 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameSTOCK Pax7tm1(cre)Mrc Mapk14tm2Nbr/JpellH
Alternative nameC57BL/6J- Mapk14tm2Nbr Pax7tm1(cre)Mrc
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolMapk14tm2Nbr, Pax7tm1(cre)Mrc
Gene/Transgene symbolMapk14, Pax7

Information from provider

ProviderSarah Shorne
Provider affiliationPharmacology, University of Cambridge
Genetic informationKnock-out of Mapk14/p38alpha only in the presence of cre recombinase.
Phenotypic informationHomozygous:
Very mild growth retardation.

Heterozygous:
Unsure if exhibited in heterozygote.
Breeding historyp38flox mice, expressing loxP-flanked Mapk14/p38alpha, crossed with Pax7-cre mice.
References
  • Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.;Adams R H, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda A R, ;2000;Molecular cell;6;109-16; 10949032
  • Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.;Keller Charles, Hansen Mark S, Coffin Cheryl M, Capecchi Mario R, ;2004;Genes & development;18;2608-13; 15520281
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requirednot known
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • decreased circulating triglyceride level / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
MGI phenotypes (gene matching)
  • abnormal erythropoiesis / MGI
  • abnormal angiogenesis / MGI
  • absent myocardial trabeculae / MGI
  • altered response to myocardial infarction / MGI
  • small liver / MGI
  • pale liver / MGI
  • anemia / MGI
  • abnormal blood vessel morphology / MGI
  • poor circulation / MGI
  • abnormal placenta morphology / MGI
  • abnormal placenta development / MGI
  • decreased trophoblast giant cell number / MGI
  • abnormal placenta labyrinth morphology / MGI
  • pale yolk sac / MGI
  • no abnormal phenotype detected / MGI
  • thin myocardium / MGI
  • decreased myocardial infarction size / MGI
  • abnormal placenta vasculature / MGI
  • absent placental labyrinth / MGI
  • pallor / MGI
  • embryonic growth retardation / MGI
  • abnormal vitelline vascular remodeling / MGI
  • abnormal muscle fiber morphology / MGI
  • abnormal trophoblast layer morphology / MGI
  • increased double-negative T cell number / MGI
  • decreased T cell proliferation / MGI
  • decreased cardiac muscle contractility / MGI
  • hematopoietic system phenotype / MGI
  • abnormal T-helper 1 physiology / MGI
  • decreased circulating glucose level / MGI
  • abnormal cell physiology / MGI
  • embryonic lethality during organogenesis / MGI
  • impaired placental function / MGI
  • decreased interferon-alpha secretion / MGI
  • decreased interferon-gamma secretion / MGI
  • abnormal fetal cardiomyocyte morphology / MGI
  • abnormal placental labyrinth vasculature morphology / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • decreased placental labyrinth size / MGI
  • abnormal myoblast differentiation / MGI
  • increased pancreatic beta cell proliferation / MGI
  • decreased pancreatic beta cell proliferation / MGI
  • decreased spongiotrophoblast size / MGI
  • increased embryonic tissue cell apoptosis / MGI
  • short maxilla / MGI
  • pointed snout / MGI
  • abnormal small intestine morphology / MGI
  • muscle weakness / MGI
  • abnormal muscle regeneration / MGI
  • thin diaphragm muscle / MGI
  • decreased body size / MGI
  • postnatal growth retardation / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • no phenotypic analysis / MGI
  • nervous system phenotype / MGI
  • decreased satellite cell number / MGI
  • myositis / MGI
  • abnormal nasal capsule morphology / MGI
  • decreased skeletal muscle mass / MGI
  • cachexia / MGI
  • muscle phenotype / MGI
  • embryo phenotype / MGI
  • digestive/alimentary phenotype / MGI
  • cellular phenotype / MGI
  • abnormal serous gland morphology / MGI
  • decreased skeletal muscle fiber diameter / MGI
  • skeletal muscle fibrosis / MGI
  • decreased birth body size / MGI
  • decreased skeletal muscle weight / MGI
  • postnatal lethality, incomplete penetrance / MGI

Literature references

  • Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.;Adams R H, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda A R, ;2000;Molecular cell;6;109-16; 10949032
  • Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.;Keller Charles, Hansen Mark S, Coffin Cheryl M, Capecchi Mario R, ;2004;Genes & development;18;2608-13; 15520281

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).